These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3680599)

  • 1. Phenylpropanolamine: effects on subjective and cardiovascular variables at recommended over-the-counter dose levels.
    Liebson I; Bigelow G; Griffiths RR; Funderburk FR
    J Clin Pharmacol; 1987 Sep; 27(9):685-93. PubMed ID: 3680599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of phenylpropanolamine on ambulatory blood pressure.
    Goodman RP; Wright JT; Barlascini CO; McKenney JM; Lambert CM
    Clin Pharmacol Ther; 1986 Aug; 40(2):144-7. PubMed ID: 3731678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A controlled clinical trial of the cardiovascular and psychological effects of phenylpropanolamine and caffeine.
    Noble R
    Drug Intell Clin Pharm; 1988 Apr; 22(4):296-9. PubMed ID: 3286173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of the pressor effect of phenylpropanolamine in healthy subjects.
    Blackburn GL; Morgan JP; Lavin PT; Noble R; Funderburk FR; Istfan N
    JAMA; 1989 Jun; 261(22):3267-72. PubMed ID: 2716162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective profile of phenylpropanolamine: absence of stimulant or euphorigenic effects at recommended dose levels.
    Morgan JP; Funderburk FR; Blackburn GL; Noble R
    J Clin Psychopharmacol; 1989 Feb; 9(1):33-8. PubMed ID: 2651492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of multiple doses of phenylpropanolamine on the blood pressure of patients whose hypertension was controlled with beta blockers.
    O'Connell MB; Gross CR
    Pharmacotherapy; 1991; 11(5):376-81. PubMed ID: 1684039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion?
    Swain RA; Harsha DM; Baenziger J; Saywell RM
    Clin J Sport Med; 1997 Jul; 7(3):168-73. PubMed ID: 9262882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of phenylpropanolamine on human sympathetic nervous system function.
    Lake CR; Chernow B; Zaloga G; Labow J; Quirk R; Hedges SM
    Neuropsychopharmacology; 1988 May; 1(2):163-8. PubMed ID: 3251497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of phenylpropanolamine on blood pressure during upright bicycle exercise in normal subjects.
    Davies SF; McArthur CD; Husebye DG; Maddy MM; O'Connell MB; Pentel PR
    Int J Obes; 1989; 13(4):505-10. PubMed ID: 2676877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of phenylpropanolamine in the management of moderate obesity.
    Schteingart DE
    Int J Obes Relat Metab Disord; 1992 Jul; 16(7):487-93. PubMed ID: 1323545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acute effect of phenylpropanolamine and brompheniramine on blood pressure in controlled hypertension: a randomized double-blind crossover trial.
    Petrulis AS; Imperiale TF; Speroff T
    J Gen Intern Med; 1991; 6(6):503-6. PubMed ID: 1684991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylpropanolamine: reinforcing and subjective effects in normal human volunteers.
    Chait LD; Uhlenhuth EH; Johanson CE
    Psychopharmacology (Berl); 1988; 96(2):212-7. PubMed ID: 3148148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of phenylpropanolamine on 24-hour blood pressure in normotensive subjects administered indomethacin.
    McKenney JM; Wright JT; Katz GM; Goodman RP
    DICP; 1991 Mar; 25(3):234-9. PubMed ID: 2028627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of phenylpropanolamine and isometric exercise on blood pressure.
    Pentel PR; Eisen T
    Int J Obes; 1988; 12(3):199-204. PubMed ID: 3391736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selegiline, phenylpropanolamine, or a combination of both on physiologic and behavioral variables in healthy dogs.
    Cohn LA; Dodam JR; Szladovits B
    Am J Vet Res; 2002 Jun; 63(6):827-32. PubMed ID: 12061528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic doses of phenylpropanolamine increase supine systolic blood pressure.
    Pentel PR; Aaron C; Paya C
    Int J Obes; 1985; 9(2):115-9. PubMed ID: 4030197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in blood pressure following escalating doses of phenylpropanolamine and a suggested protocol for monitoring.
    Segev G; Westropp JL; Kulik C; Lavy E
    Can Vet J; 2015 Jan; 56(1):39-43. PubMed ID: 25565712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discriminative stimulus and subjective effects of phenylpropanolamine, mazindol and d-amphetamine in humans.
    Chait LD; Uhlenhuth EH; Johanson CE
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1665-72. PubMed ID: 3737634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of phenylpropanolamine and associated effects on blood pressure in normotensive subjects: a pilot-study.
    Dowse R; Scherzinger SS; Kanfer I
    Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):205-10. PubMed ID: 2194987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of phenylpropanolamine on withdrawal symptoms.
    Klesges RC; Klesges LM; DeBon M; Shelton ML; Isbell TR; Klem ML
    Psychopharmacology (Berl); 1995 May; 119(1):85-91. PubMed ID: 7675954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.